2021 · International journal of environmental research and public health · open access
Diagnostic Test Accuracy of First-Void Urine Human Papillomaviruses for Presence Cervical HPV in Women: Systematic Review and Meta-Analysis
Bober et al.
The finding, in our words
Pooled sensitivity of 78% and specificity of 89% for high-risk HPV in first-void urine indicate acceptable diagnostic test accuracy for cervical HPV, supporting its use as a non-invasive decentralised screening option.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
A time-resolved fluorescence assay detected HPV16-specific IgG in first-void urine with strong correlation to paired serum across four immunoassays in 225 healthy women, supporting first-void urine as a non-invasive alternative to venous blood for HPV antibody monitoring.
Lipovac et al., Journal of virological methods · source ↗
First-void urine IgG remained stable for at least 14 days at room temperature when stored with conservation medium. Amicon filtration with Melon Gel purification enriched HPV16-specific IgG that correlated strongly with serum levels, supporting non-invasive disease monitoring and vaccine impact assessment.
First-void urine tested on the GeneXpert platform detected high-risk HPV DNA with 84.8 per cent sensitivity and 92.3 per cent specificity compared with clinician-collected cervical samples, with substantial agreement (kappa 0.77) and high patient acceptability among 100 HIV-positive women in Zambia, suggesting that decentralised urine self-sampling with an EDTA preservative could widen cervical cancer screening coverage where invasive methods deter uptake.
First-void urine HPV antibody concentrations were lower than serum but showed strong positive correlations across four HPV types. The VLP-based multiplex ELISA demonstrated moderate to good agreement with the GST-L1 assay, confirming that self-collected first-void urine offers a viable non-invasive alternative for assessing HPV vaccine responses in decentralised studies, though larger investigations are needed to establish routine feasibility.
Pattyn et al., Journal of medical virology · source ↗
This study demonstrates for the first time that HPV vaccine antibodies can be detected in first-void urine from young women, with levels correlating strongly to serum (Spearman r 0.64–0.88). This non-invasive approach could support large-scale epidemiological studies and vaccine monitoring, reducing the need for venous blood draws, though further optimisation and validation is needed.
Van Keer et al., Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology (paywalled) · source ↗